Stratification of risk of death in severe acute alcoholic hepatitis using a panel of adipokines and cytokines

Alcoholism: Clinical and Experimental Research

Volumn 38, Issue 11, 2014, Pages 2712-2721

  Rachakonda, Vikrant ^a   Gabbert, Charles ^a   Raina, Amit ^a,b   Li, Huanan ^a,c   Malik, Shahid ^a   Delany, James P ^a   Behari, Jaideep ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Acute alcoholic hepatitis; Adipose tissue metabolism; Biomarker; Interleukin 6; Serum lipidomic analysis

Indexed keywords

ADIPOCYTOKINE; BIOLOGICAL MARKER; CYTOKINE;

ACUTE DISEASE; ADULT; BLOOD; CASE CONTROL STUDY; FEMALE; HEPATITIS, ALCOHOLIC; HUMAN; MALE; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TRENDS;

ACUTE DISEASE; ADIPOKINES; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; HEPATITIS, ALCOHOLIC; HUMANS; MALE; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84911432449     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/acer.12558     Document Type: Article

References (45)

1. Addolorato G, Capristo E, Greco AV, Stefanini GF, Gasbarrini G (1997) Energy expenditure, substrate oxidation, and body composition in subjects with chronic alcoholism: new findings from metabolic assessment. Alcohol Clin Exp Res 21:962-967.
2. Addolorato G, Capristo E, Greco AV, Stefanini GF, Gasbarrini G (1998) Influence of chronic alcohol abuse on body weight and energy metabolism: is excess ethanol consumption a risk factor for obesity or malnutrition? J Intern Med 244:387-395.
3. Ajuwon KM, Spurlock ME (2004) Direct regulation of lipolysis by interleukin-15 in primary pig adipocytes. Am J Physiol Regul Integr Comp Physiol 287:R608-R611.
4. Bell LN, Wang J, Muralidharan S, Chalasani S, Fullenkamp AM, Wilson LA, Sanyal AJ, Kowdley KV, Neuschwander-Tetri BA, Brunt EM, McCullough AJ, Bass NM, Diehl AM, Unalp-Arida A, Chalasani N, Nonalcoholic Steatohepatitis Clinical Research Network (2012) Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: a pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study. Hepatology 56:1311-1318.
5. Bertolani C, Sancho-Bru P, Failli P, Bataller R, Aleffi S, DeFranco R, Mazzinghi B, Romagnani P, Milani S, Gines P, Colmenero J, Parola M, Gelmini S, Tarquini R, Laffi G, Pinzani M, Marra F (2006) Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells. Am J Pathol 169:2042-2053.
6. Cawthorn WP, Sethi JK (2008) TNF-alpha and adipocyte biology. FEBS Lett 582:117-131.
7. Dunn W, Jamil LH, Brown LS, Wiesner RH, Kim WR, Menon KV, Malinchoc M, Kamath PS, Shah V (2005) MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology 41:353-358.
8. Endo M, Masaki T, Seike M, Yoshimatsu H (2007) TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c). Exp Biol Med 232:614-621.
9. European Association for the Study of Liver (2012) EASL clinical practical guidelines: management of alcoholic liver disease. J Hepatol 57:399-420.
10. Fleming KM, Aithal GP, Card TR, West J (2010) The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study. Aliment Pharmacol Ther 32:1343-1350.
11. Forrest EH, Gleeson D (2012) Is a liver biopsy necessary in alcoholic hepatitis? J Hepatol 56:1427-1428.
12. Fujimoto M, Uemura M, Nakatani Y, Tsujita S, Hoppo K, Tamagawa T, Kitano H, Kikukawa M, Ann T, Ishii Y, Kojima H, Sakurai S, Tanaka R, Namisaki T, Noguchi R, Higashino T, Kikuchi E, Nishimura K, Takaya A, Fukui H (2000) Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance. Alcohol Clin Exp Res 24:48S-54S.
13. Garrow JS, Webster J (1985) Quetelet's index (W/H2) as a measure of fatness. Int J Obes 9:147-153.
14. Gastaldelli A, Harrison SA, Belfort-Aguilar R, Hardies LJ, Balas B, Schenker S, Cusi K (2009) Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis. Hepatology 50:1087-1093.
15. Hamid R, Forrest EH (2011) Is histology required for the diagnosis of alcoholic hepatitis? A review of published randomised controlled trials. Gut 60:A233.
16. Hermans MP, Levy JC, Morris RJ, Turner RC (1999) Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes. Diabetes 48:1779-1786.
17. Hill DB, Marsano L, Cohen D, Allen J, Shedlofsky S, McClain CJ (1992) Increased plasma interleukin-6 concentrations in alcoholic hepatitis. J Lab Clin Med 119:547-552.
18. Kang L, Chen X, Sebastian BM, Pratt BT, Bederman IR, Alexander JC, Previs SF, Nagy LE (2007a) Chronic ethanol and triglyceride turnover in white adipose tissue in rats: inhibition of the anti-lipolytic action of insulin after chronic ethanol contributes to increased triglyceride degradation. J Biol Chem 282:28465-28473.
19. Kang L, Sebastian BM, Pritchard MT, Pratt BT, Previs SF, Nagy LE (2007b) Chronic ethanol-induced insulin resistance is associated with macrophage infiltration into adipose tissue and altered expression of adipocytokines. Alcohol Clin Exp Res 31:1581-1588.
20. Kangani CO, Kelley DE, Delany JP (2008) New method for GC/FID and GC-C-IRMS analysis of plasma free fatty acid concentration and isotopic enrichment. J Chromatogr B Analyt Technol Biomed Life Sci 873:95-101.
21. Lucey MR, Mathurin P, Morgan TR (2009) Alcoholic hepatitis. N Engl J Med 360:2758-2769.
22. Maddrey WC, Boitnott JK, Bedine MS, Weber FL Jr, Mezey E, White RI Jr (1978) Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 75:193-199.
23. Marra F, Bertolani C (2009) Adipokines in liver diseases. Hepatology 50:957-969.
24. Mathurin P, Duchatelle V, Ramond MJ, Degott C, Bedossa P, Erlinger S, Benhamou JP, Chaput JC, Rueff B, Poynard T (1996) Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology 110:1847-1853.
25. Mookerjee RP, Lackner C, Stauber R, Stadlbauer V, Deheragoda M, Aigelsreiter A, Jalan R (2011) The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis. J Hepatol 55:1103-1111.
26. Mookerjee RP, Sen S, Davies NA, Hodges SJ, Williams R, Jalan R (2003) Tumour necrosis factor alpha is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis. Gut 52:1182-1187.
27. Naveau S, Cassard-Doulcier AM, Njike-Nakseu M, Bouchet-Delbos L, Barri-Ova N, Boujedidi H, Dauvois B, Balian A, Maitre S, Prevot S, Dagher I, Agostini H, Grangeot-Keros L, Emilie D, Perlemuter G (2010) Harmful effect of adipose tissue on liver lesions in patients with alcoholic liver disease. J Hepatol 52:895-902.
28. Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JC (1997) Excess weight risk factor for alcoholic liver disease. Hepatology 25:108-111.
29. O'Shea RS, Dasarathy S, McCullough AJ, Practice Guideline Committee of the American Association for the Study of Liver Diseases, Practice Parameters Committee of the American College of Gastroenterology (2010) Alcoholic liver disease. Hepatology 51:307-328.
30. Perkins NJ, Schisterman EF (2005) The Youden Index and the optimal cut-point corrected for measurement error. Biom J 47:428-441.
31. Purohit V, Gao B, Song BJ (2009) Molecular mechanisms of alcoholic fatty liver. Alcohol Clin Exp Res 33:191-205.
32. Qatanani M, Szwergold NR, Greaves DR, Ahima RS, Lazar MA (2009) Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice. J Clin Investig 119:531-539.
33. Rambaldi A, Saconato HH, Christensen E, Thorlund K, Wetterslev J, Gluud C (2008) Systematic review: glucocorticosteroids for alcoholic hepatitis-a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials. Aliment Pharmacol Ther 27:1167-1178.
34. Rogers CQ, Ajmo JM, You M (2008) Adiponectin and alcoholic fatty liver disease. IUBMB Life 60:790-797.
35. Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, O'Rahilly S (2001) Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 50:2199-2202.
36. Schisterman EF, Perkins NJ, Liu A, Bondell H (2005) Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples. Epidemiology 16:73-81.
37. Sheron N, Bird G, Goka J, Alexander G, Williams R (1991) Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis. Clin Exp Immunol 84:449-453.
38. Sheth M, Riggs M, Patel T (2002) Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis. BMC Gastroenterol 2:2.
39. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA (2001) The hormone resistin links obesity to diabetes. Nature 409:307-312.
40. Trujillo ME, Sullivan S, Harten I, Schneider SH, Greenberg AS, Fried SK (2004) Interleukin-6 regulates human adipose tissue lipid metabolism and leptin production in vitro. J Clin Endocrinol Metab 89:5577-5582.
41. Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27:1487-1495.
42. Wei X, Shi X, Zhong W, Zhao Y, Tang Y, Sun W, Yin X, Bogdanov B, Kim S, McClain C, Zhou Z, Zhang X (2013) Chronic alcohol exposure disturbs lipid homeostasis at the adipose tissue-liver axis in mice: analysis of triacylglycerols using high-resolution mass spectrometry in combination with in vivo metabolite deuterium labeling. PLoS One 8:e55382.
43. Whitcomb DC, Yadav D, Adam S, Hawes RH, Brand RE, Anderson MA, Money ME, Banks PA, Bishop MD, Baillie J, Sherman S, DiSario J, Burton FR, Gardner TB, Amann ST, Gelrud A, Lo SK, DeMeo MT, Steinberg WM, Kochman ML, Etemad B, Forsmark CE, Elinoff B, Greer JB, O'Connell M, Lamb J, Barmada MM; North American Pancreatic Study Group (2008) Multicenter approach to recurrent acute and chronic pancreatitis in the United States: the North American Pancreatitis Study 2 (NAPS2). Pancreatology 8:520-531.
44. Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ (2003) The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Investig 112:91-100.
45. Zhong W, Zhao Y, Tang Y, Wei X, Shi X, Sun W, Sun X, Yin X, Sun X, Kim S, McClain CJ, Zhang X, Zhou Z (2012) Chronic alcohol exposure stimulates adipose tissue lipolysis in mice: role of reverse triglyceride transport in the pathogenesis of alcoholic steatosis. Am J Pathol 180:998-1007.